975P The clinical impact of urinary protein creatinine ratio and AFP at six weeks in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Autor: Tsuchiya, K., Yamada, M., Yasui, Y., Yamazaki, Y., Uchihara, N., Suzuki, K., Tanaka, Y., Miyamoto, H., Keitoku, T., Okada, R., Higuchi, M., Takaura, K., Tanaka, S., Maeyashiki, C., Tamaki, N., Nakanishi, H., Kurosaki, M., Izumi, N.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S604-S605
Databáze: ScienceDirect